Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function.
Herrington
D M
DM
Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Klein
K P
KP
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000187:drug effects*; D004730:Endothelium, Vascular / Q000187:drug effects*; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000494:pharmacology; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology* / Q000627:therapeutic use; D013629:Tamoxifen / Q000031:analogs & derivatives* / Q000494:pharmacology; D016387:Women's Health
D008078:Cholesterol, LDL; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; C038345:droloxifene; D020849:Raloxifene Hydrochloride